520 related articles for article (PubMed ID: 27298516)
41. In vivo intra-luteal implants of prostaglandin (PG) E1 or E2 (PGE1, PGE2) prevent luteolysis in cows. II: mRNA for PGF2α, EP1, EP2, EP3 (A-D), EP3A, EP3B, EP3C, EP3D, and EP4 prostanoid receptors in luteal tissue.
Weems YS; Bridges PJ; Jeoung M; Arreguin-Arevalo JA; Nett TM; Vann RC; Ford SP; Lewis AW; Neuendorff DA; Welsh TH; Randel RD; Weems CW
Prostaglandins Other Lipid Mediat; 2012 Jan; 97(1-2):60-5. PubMed ID: 22120546
[TBL] [Abstract][Full Text] [Related]
42. EP2 and EP4 receptors mediate PGE2 induced relaxation in murine colonic circular muscle: pharmacological characterization.
Martinez-Cutillas M; Mañé N; Gallego D; Jimenez M; Martin MT
Pharmacol Res; 2014 Dec; 90():76-86. PubMed ID: 25461458
[TBL] [Abstract][Full Text] [Related]
43. PGE
Gonzalez AA; Salinas-Parra N; Leach D; Navar LG; Prieto MC
Am J Physiol Renal Physiol; 2017 Oct; 313(4):F1038-F1049. PubMed ID: 28701311
[TBL] [Abstract][Full Text] [Related]
44. Prostaglandin E₂ inhibits human lung fibroblast chemotaxis through disparate actions on different E-prostanoid receptors.
Li YJ; Wang XQ; Sato T; Kanaji N; Nakanishi M; Kim M; Michalski J; Nelson AJ; Sun JH; Farid M; Basma H; Patil A; Toews ML; Liu X; Rennard SI
Am J Respir Cell Mol Biol; 2011 Jan; 44(1):99-107. PubMed ID: 20203295
[TBL] [Abstract][Full Text] [Related]
45. Prostaglandin E2 activates the mTORC1 pathway through an EP4/cAMP/PKA- and EP1/Ca2+-mediated mechanism in the human pancreatic carcinoma cell line PANC-1.
Chang HH; Young SH; Sinnett-Smith J; Chou CE; Moro A; Hertzer KM; Hines OJ; Rozengurt E; Eibl G
Am J Physiol Cell Physiol; 2015 Nov; 309(10):C639-49. PubMed ID: 26310818
[TBL] [Abstract][Full Text] [Related]
46. Opposing effects of prostaglandin E
Carboneau BA; Allan JA; Townsend SE; Kimple ME; Breyer RM; Gannon M
Mol Metab; 2017 Jun; 6(6):548-559. PubMed ID: 28580285
[TBL] [Abstract][Full Text] [Related]
47. Cyclooxygenase-2 inhibits UVB-induced apoptosis in mouse skin by activating the prostaglandin E2 receptors, EP2 and EP4.
Chun KS; Akunda JK; Langenbach R
Cancer Res; 2007 Mar; 67(5):2015-21. PubMed ID: 17332329
[TBL] [Abstract][Full Text] [Related]
48. Prostaglandin E2 increases proximal tubule fluid reabsorption, and modulates cultured proximal tubule cell responses via EP1 and EP4 receptors.
Nasrallah R; Hassouneh R; Zimpelmann J; Karam AJ; Thibodeau JF; Burger D; Burns KD; Kennedy CR; Hébert RL
Lab Invest; 2015 Sep; 95(9):1044-55. PubMed ID: 26121313
[TBL] [Abstract][Full Text] [Related]
49. Prostaglandin E2 contributes to the synthesis of brain-derived neurotrophic factor in primary sensory neuron in ganglion explant cultures and in a neuropathic pain model.
Cruz Duarte P; St-Jacques B; Ma W
Exp Neurol; 2012 Apr; 234(2):466-81. PubMed ID: 22309829
[TBL] [Abstract][Full Text] [Related]
50. Selective regulation of RNK-16 cell matrix metalloproteinases by the EP4 subtype of prostaglandin E2 receptor.
Zeng L; An S; Goetzl EJ
Biochemistry; 1996 Jun; 35(22):7159-64. PubMed ID: 8679543
[TBL] [Abstract][Full Text] [Related]
51. E prostanoid 2 (EP2)/EP4-mediated suppression of antigen-specific human T-cell responses by prostaglandin E2.
Okano M; Sugata Y; Fujiwara T; Matsumoto R; Nishibori M; Shimizu K; Maeda M; Kimura Y; Kariya S; Hattori H; Yokoyama M; Kino K; Nishizaki K
Immunology; 2006 Jul; 118(3):343-52. PubMed ID: 16827895
[TBL] [Abstract][Full Text] [Related]
52. Prostaglandin E2 regulates interleukin-1beta-induced matrix metalloproteinase-3 production in human gingival fibroblasts.
Ruwanpura SM; Noguchi K; Ishikawa I
J Dent Res; 2004 Mar; 83(3):260-5. PubMed ID: 14981131
[TBL] [Abstract][Full Text] [Related]
53. Prostaglandin E2 suppresses poly I: C-stimulated cytokine production via EP2 and EP3 in immortalized human corneal epithelial cells.
Ueta M; Matsuoka T; Sotozono C; Kinoshita S
Cornea; 2012 Nov; 31(11):1294-8. PubMed ID: 22475642
[TBL] [Abstract][Full Text] [Related]
54. Roles of the central prostaglandin EP3 receptors in cardiovascular regulation in rats.
Ariumi H; Takano Y; Masumi A; Takahashi S; Hirabara Y; Honda K; Saito R; Kamiya HO
Neurosci Lett; 2002 May; 324(1):61-4. PubMed ID: 11983295
[TBL] [Abstract][Full Text] [Related]
55. Dual Blockade of EP2 and EP4 Signaling is Required for Optimal Immune Activation and Antitumor Activity Against Prostaglandin-Expressing Tumors.
Francica BJ; Holtz A; Lopez J; Freund D; Chen A; Wang D; Powell D; Kipper F; Panigrahy D; Dubois RN; Whiting CC; Prasit P; Dubensky TW
Cancer Res Commun; 2023 Aug; 3(8):1486-1500. PubMed ID: 37559947
[TBL] [Abstract][Full Text] [Related]
56. Growth regulation of primary human keratinocytes by prostaglandin E receptor EP2 and EP3 subtypes.
Konger RL; Malaviya R; Pentland AP
Biochim Biophys Acta; 1998 Feb; 1401(2):221-34. PubMed ID: 9531979
[TBL] [Abstract][Full Text] [Related]
57. Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation.
Kay LJ; Yeo WW; Peachell PT
Br J Pharmacol; 2006 Apr; 147(7):707-13. PubMed ID: 16432506
[TBL] [Abstract][Full Text] [Related]
58. Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia.
McCullough L; Wu L; Haughey N; Liang X; Hand T; Wang Q; Breyer RM; Andreasson K
J Neurosci; 2004 Jan; 24(1):257-68. PubMed ID: 14715958
[TBL] [Abstract][Full Text] [Related]
59. Prostaglandin E
Li H; Chen HY; Liu WX; Jia XX; Zhang JG; Ma CL; Zhang XJ; Yu F; Cong B
Immunol Lett; 2017 Nov; 191():63-72. PubMed ID: 28963072
[TBL] [Abstract][Full Text] [Related]
60. The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs.
Suzawa T; Miyaura C; Inada M; Maruyama T; Sugimoto Y; Ushikubi F; Ichikawa A; Narumiya S; Suda T
Endocrinology; 2000 Apr; 141(4):1554-9. PubMed ID: 10746663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
